For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250820:nRST1426Wa&default-theme=true
RNS Number : 1426W PI Industries Ltd. 20 August 2025
THE FOLLOWING ANNOUNCEMENT IS BEING MADE PURSUANT TO THE REQUIREMENTS OF RULE
19.6(C) OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") WHICH, AMONGST
OTHER THINGS, REQUIRES A PARTY TO AN OFFER TO MAKE AN ANNOUNCEMENT AT THE END
OF A PERIOD OF 12 MONTHS FROM THE DATE ON WHICH AN OFFER PERIOD ENDED
CONFIRMING WHETHER IT HAS TAKEN, OR NOT TAKEN, THE COURSE OF ACTION SET OUT IN
ITS STATED INTENTIONS
20 August 2025
PI INDUSTRIES MANAGEMENT CONSULTANCIES L.L.C.
("Bidco")
Rule 19.6(c) confirmation with respect to post-offer intentions regarding
Plant Health Care Limited (formerly Plant Health Care plc) ("PHC")
Bidco announces that, further to the completion of its recommended cash
acquisition of the entire issued and to be issued ordinary share capital of
PHC , which was effected by way of a scheme of arrangement under Part 26 of
the Companies Act 2006 and became effective on 20 August 2024, it has duly
confirmed in writing to The Panel on Takeovers and Mergers that in accordance
with the requirements of Rule 19.6(c) of the Code that Bidco has complied
with its post-offer statements of intent made pursuant to Rules 2.7(c)(viii)
and 24.2 of the Code, as originally detailed in the Rule 2.7 announcement
dated 26 June 2024 and the scheme document published on 10 July 2024.
Enquiries:
Zeus (financial adviser to Bidco and PI) Tel: +44 20 3829 5000
Nick Cowles
James Edis
Louisa Waddell
Important Notice
Zeus Capital Limited ("Zeus"), which is authorised and regulated by the FCA in
the United Kingdom, is acting exclusively for PI and Bidco as financial
adviser and no one else in connection with the matters referred to in this
announcement and will not be responsible to anyone other than PI and Bidco for
providing the protections afforded to clients of Zeus, or for providing advice
in relation to the matters referred to in this announcement. Neither Zeus nor
any of its affiliates owes or accepts any duty, liability or responsibility
whatsoever (whether direct or indirect, whether in contract, in tort, under
statute or otherwise) to any person who is not a client of Zeus in connection
with the matters referred to in this announcement, any statement contained
herein or otherwise.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END OUPSEWFISEISEEA